AGGRESSIVE FIBROMATOSIS
Clinical trials for AGGRESSIVE FIBROMATOSIS explained in plain language.
Never miss a new study
Get alerted when new AGGRESSIVE FIBROMATOSIS trials appear
Sign up with your email to follow new studies for AGGRESSIVE FIBROMATOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare tumor patients: drug trial targets desmoid growths without surgery
Disease control OngoingThis study tests a drug called nirogacestat in 20 Japanese adults with desmoid tumors (also called aggressive fibromatosis) that are growing. The goal is to see if the drug can shrink or control these non-cancerous but painful tumors. Participants take the drug by mouth, and doct…
Matched conditions: AGGRESSIVE FIBROMATOSIS
Phase: PHASE2 • Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany • Aim: Disease control
Last updated May 26, 2026 08:30 UTC
-
France launches Largest-Ever study on rare tumor disease
Knowledge-focused OngoingThis study aims to create the largest French group of people diagnosed with aggressive fibromatosis (a rare, non-cancerous tumor) since 2016. Researchers will collect medical and genetic information to better understand the disease and its link to a hereditary condition called fa…
Matched conditions: AGGRESSIVE FIBROMATOSIS
Phase: NA • Sponsor: Centre Oscar Lambret • Aim: Knowledge-focused
Last updated May 26, 2026 08:40 UTC